Nilo Therapeutics' Series A round was led by The Column Group, DCVC Bio, and Lux Capital. The preclinical startup is developing drugs targeting neural circuits that control systemic inflammation.
Nilo Therapeutics' Series A round was led by The Column Group, DCVC Bio, and Lux Capital. The preclinical startup is developing drugs targeting neural circuits that control systemic inflammation.
Clinical Architecture Founder and CEO Charlie Harp shares with us how a data assessment framework he developed, the Patient Information Quality Improvement (PIQI) framework, functions as a healthcare data quality taxonomy to address these issues. See the full story
To meaningfully scale mental health care — and improve outcomes along the way — we must move beyond the rigid constraints of episodic care and toward a model that is continuous, intelligent, and adaptive to individual needs.
Historically, many medical products and practices have been designed around the male anatomy or physician convenience rather than women's needs, pointed out Abbie Clary, executive director of health for all at CannonDesign.
She cited examples like artificial hips that fail more often in women, as well as CPR mannequins modeled on the male anatomy. There's also the fact that most childbirths take place with the woman on her back — a practice that prioritizes the doctors' ease over women's comfort and physiology.
The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities.
In this episode, we're joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women's health research and what she hopes to achieve as a founding member of the Milken Institute's Women's Health Network.
No comments